Covea Finance

Position in ABT — Abbott Laboratories

CIK 1636948 PARIS, I0

Position in ABT

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$4,831,542

-$30,165,478 QoQ

Shares Held

53,246

-84.4% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#710

of 2,959 holders

Holding Since

Sep 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Covea Finance holds $33,411,856 across 4 Medical Devices names. ABT ranks #4 (14.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SYK	Stryker Corp	42,907	$13,508,839
2	GMED	Globus Medical Inc	97,900	$7,735,079
3	EW	Edwards Lifesciences Corp	81,101	$7,336,396
4	ABT	Abbott Laboratories This page	53,246	$4,831,542

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,831,542	53,246	-84.4%	Shares	Sole	2026-07-13
2026-03-31	$34,997,020	340,869	-7.6%	Shares	Sole	2026-04-15
2025-12-31	$46,226,246	368,954	+3.9%	Shares	Sole	2026-01-07
2025-09-30	$47,555,932	355,054	-7.8%	Shares	Sole	2025-10-16
2025-06-30	$52,398,396	385,254	+31.3%	Shares	Sole	2025-07-15
2025-03-31	$38,926,673	293,454	+178.0%	Shares	Sole	2025-04-22
2024-09-30	$12,034,211	105,554	0.0%	Shares	Sole	2024-10-10
2024-06-30	$10,968,116	105,554	-69.5%	Shares	Sole	2024-07-16
2024-03-31	$39,326,928	346,005	-19.2%	Shares	Sole	2024-04-19
2023-12-31	$47,143,531	428,305	-6.9%	Shares	Sole	2024-01-08
2023-09-30	$44,541,799	459,905	+148.3%	Shares	Sole	2023-10-10
2023-06-30	$20,191,049	185,205	-17.4%	Shares	Sole	2023-07-07
2023-03-31	$22,712,719	224,301	-45.9%	Shares	Sole	2023-04-17
2022-12-31	$45,535,182	414,748	+36.9%	Shares	Sole	2023-02-02
2022-09-30	$29,303,572	302,848	—	Shares	Sole	2022-10-27
No filing history on record for this holder in this stock.